These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37178894)

  • 1. pH-responsive bufadienolides nanocrystals decorated by chitosan quaternary ammonium salt for treating colon cancer.
    Tian Z; Wu X; Peng L; Yu N; Gou G; Zuo W; Yang J
    Int J Biol Macromol; 2023 Jul; 242(Pt 2):124819. PubMed ID: 37178894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocrystals with different stabilizers overcome the mucus and epithelial barriers for oral delivery of multicomponent Bufadienolides.
    Tian Z; Zhao Y; Mai Y; Qiao F; Guo J; Dong L; Niu Y; Gou G; Yang J
    Int J Pharm; 2022 Mar; 616():121522. PubMed ID: 35093460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
    Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P
    Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
    Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F
    Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Weng Y; Wang L; He H; Yang J; Tang X
    Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan.
    Qiao F; Jiang Z; Fang W; Sun J; Hu Q
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
    Song Q; Jia J; Niu X; Zheng C; Zhao H; Sun L; Zhang H; Wang L; Zhang Z; Zhang Y
    Nanoscale; 2019 Aug; 11(34):15958-15970. PubMed ID: 31418432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel pH-responsive quaternary ammonium chitosan-liposome nanoparticles for periodontal treatment.
    Hu F; Zhou Z; Xu Q; Fan C; Wang L; Ren H; Xu S; Ji Q; Chen X
    Int J Biol Macromol; 2019 May; 129():1113-1119. PubMed ID: 30218737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
    Verma A; Sharma S; Gupta PK; Singh A; Teja BV; Dwivedi P; Gupta GK; Trivedi R; Mishra PR
    Acta Biomater; 2016 Feb; 31():288-300. PubMed ID: 26685755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silver nanoparticles functionalized Paclitaxel nanocrystals enhance overall anti-cancer effect on human cancer cells.
    Muhammad N; Zhao H; Song W; Gu M; Li Q; Liu Y; Li C; Wang J; Zhan H
    Nanotechnology; 2021 Feb; 32(8):085105. PubMed ID: 33197899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP/Hyals dually responsive core-shell hyaluronan/chitosan-based drug nanocarrier for potential application in breast cancer therapy.
    Li H; Zhuang S; Yang Y; Zhou F; Rong J; Zhao J
    Int J Biol Macromol; 2021 Jul; 183():839-851. PubMed ID: 33965490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon.
    Li P; Yang Z; Wang Y; Peng Z; Li S; Kong L; Wang Q
    J Microencapsul; 2015; 32(1):40-5. PubMed ID: 25198909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery.
    Samprasit W; Opanasopit P; Chamsai B
    Pharm Dev Technol; 2021 Mar; 26(3):362-372. PubMed ID: 33423571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy.
    Gao Y; Qiu W; Liang M; Ma X; Ye M; Xue P; Kang Y; Deng J; Xu Z
    Acta Biomater; 2022 Jul; 147():299-313. PubMed ID: 35640802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells.
    Samprasit W; Opanasopit P; Chamsai B
    J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1221-1233. PubMed ID: 34919783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine encapsulated chitosan succinate-sodium alginate macromolecular complex beads for colon cancer targeted delivery: in vitro evaluation.
    Sinha P; Udhumansha U; Rathnam G; Ganesh M; Jang HT
    Int J Biol Macromol; 2018 Oct; 117():840-850. PubMed ID: 29807085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer.
    Zhao C; Cao W; Zheng H; Xiao Z; Hu J; Yang L; Chen M; Liang G; Zheng S; Zhao C
    Int J Nanomedicine; 2019; 14():1597-1618. PubMed ID: 30880968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization of cross-linked quaternary chitosan salt and its adsorption of perchlorate from water].
    Xie YH; Li SY; Liu GL
    Huan Jing Ke Xue; 2011 Sep; 32(9):2537-42. PubMed ID: 22165217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment.
    Wang J; Zhang L; Xin H; Guo Y; Zhu B; Su L; Wang S; Zeng J; Chen Q; Deng R; Wang Z; Wang J; Jin X; Gui S; Xu Y; Lu X
    Acta Biomater; 2022 Oct; 152():453-472. PubMed ID: 36084923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.